Solara Active Pharma Sciences Announces FY26 Annual Report and AGM Details

Solara Active Pharma Sciences Ltd has released its Annual Report for the financial year ended March 31, 2026, along with the notice for its Ninth Annual General Meeting (AGM). The AGM is scheduled for September 18, 2026, to be held virtually. The report highlights key financial and operational metrics for FY2025-26, including revenue of ₹1,375.14 Crores and EBITDA of ₹191.54 Crores. It also details the company's focus on cost optimization, R&D, and sustainability initiatives, including CSR investments of ₹0.76 Crores. The report is available on the company's website, and shareholders can participate via remote e-voting.